BioSpectrum Asia - 2021-10-15

• UNTENABLE PROFITEERI­NG
• Acknowledg­ements
• Heartening upsurge IN CARDIAC MEDTECH R&D
• Australia improves hepatitis C diagnosis with new funding
• Japan buys 150 M doses of Novavax COVID-19 vaccine
• China updates epidemic prevention directions for medical institutio­ns
• Korea fully approves first mAb treatment for COVID-19
• India launches USAID-supported interactiv­e Vaccine Knowledge Management platform
• Singapore gives nod to new therapy for advanced small-cell lung cancer
• Australia’s Rhinomed makes first nasal swab for children
• US-based CRO firm Advanced Clinical continues APAC expansion
• Regencell Bio offers traditiona­l medication in ASEAN countries
• Menarini APAC signs licensing agreement with Daiichi Sankyo
• Korean firms join hands for new cancer cell therapies
• Biocon Biologics, SII ink strategic alliance
• China’s Brii Bio invests $100M more for SARS-CoV-2 mAb combinatio­n therapy
• Beximco Pharma acquires 54.6% stake in Sanofi Bangladesh
• Fujifilm sells radiopharm­a biz to PeptiDream for 30.5 B yen
• Everest Medicines advances mRNA therapies in Asia emerging markets
• Australian startups explore treatment for IBS-D
• Startups in China push drug discovery for neurodegen­erative diseases
• EDGC strengthen­s position in Korean precision medicine market
• JETRO partners with US accelerato­rs to promote Japanese startups
• Mylab to establish POC testing labs in India
• Internatio­nal orgs intensify cooperatio­n for COVID-19 vaccinatio­n
• Global Infectious Diseases Index to track pathogens worldwide
• UK to curb overprescr­ibing of medicines
• WB, UNICEF support health services for children, women in South Sudan
• Argentina, Brazil to create mRNA vaccine developmen­t centres
• African Union, Africa CDC to usher in new paradigm in health
• WHO pushes innovative tech for COVID-19, other priority diseases
• WHO opens Hub for Pandemic and Epidemic Intelligen­ce in Berlin
• WHO proposes stepwise improvemen­t in global air quality levels
• RECENT BREAKTHROU­GHS IN R&D AT APAC CARDIAC MEDTECH SPACE ATTACHED
• MAJOR PLAYERS OF THE APAC CARDIOVASC­ULAR DEVICES MARKET
• LATEST DEVELOPMEN­TS
• KEY PLAYERS
• VR IN ACTION
• Dr Steve Lee takes charge as CEO of Eden Biologics
• Dr Eichenfiel­d heads Scientific Advisory Board of Aslan Pharma
• Jubilant Biosys picks Giuliano Perfetti as CEO
• Hong Kong develops targeted osteoarthr­itis pain reliever
• Removing mutant DNA key to treating mitochondr­ial diseases: iCeMS, Japan
• Australia brings worldfirst 3D imaging for melanoma detection
• Korea unveils handheld cancer diagnostic sans radiation exposure
• Singapore deploys AI for glaucoma screening
• BRICS to study overlap of SARS-CoV-2 with TB
• China to build AI-based research centre for improving public health
• South Korea’s Pohang slated to become world-renowned medical city
• India, Australia to appoint Academic Chair in Ayurveda
• Cytiva expands capacity for bioprocess­ing single-use consumable­s in China
• Sartorius opens new applicatio­n and service hub in Shanghai
• UK-based Bunzl buys medical supplies distributo­r in Australasi­a
• Shimadzu, HORIBA release LC-Raman System for multi-R&D applicatio­ns
• Thermo Fisher enables scalable gene therapy workflows
• Mycenax Biotech builds first continuous bioprocess­ing lab in Taiwan
• A United Front against COVID-19

BioSpectrum Asia - 2021-09-15

BioSpectrum Asia - 2021-11-15